Betabloqueadores e operações não cardíacas: o que muda após o estudo POISE?

Acute heart failure after non‐cardiac surgery: incidence, phenotypes, determinants and outcomes

“…detection of patients at increased risk of pAHF. 33,[40][41][42][43] Additionally the ESC/ESA classification could also be used to identify the patients who might develop pAHF. Third, HF with preserved ejection fraction (HFpEF) was the dominant phenotype among de novo pAHF (72%), while HF with reduced ejection fraction (HFrEF) was dominant among pAHF in chronic HF (43%).…”